Vivo Opportunity Fund Holdings, L.P. 13D and 13G filings for Unicycive Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-15 08:30 am Unchanged | 2025-03-31 | 13G | Unicycive Therapeutics, Inc. UNCY | Vivo Opportunity Fund Holdings, L.P. | 6,096,173 9.990% | 0 (Unchanged) | Filing |
| 2024-11-14 7:01 pm Purchase | 2024-10-09 | 13G | Unicycive Therapeutics, Inc. UNCY | Vivo Opportunity Fund Holdings, L.P. | 6,096,173 9.990% | 100,000 (+1.67%) | Filing |
| 2023-07-14 4:30 pm Purchase | 2023-07-11 | 13G | Unicycive Therapeutics, Inc. UNCY | Vivo Opportunity Fund Holdings, L.P. | 5,996,173 9.990% | 5,996,173 (New Position) | Filing |